Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

676.82
-16.7285-2.41%
Number of Gainers:55
Number of Losers:90
Number of Flat:8
PE:- -
High:696.26
Open:693.57
Low:666.52
Close:693.55
Volume:387.31M
Turnover:11.25B
Market Cap:471.30B
Float Cap:357.32B

Loading ...

Femasys announces Minnesota Women’s Care to implement FemVue

TIPRANKS
·
Sep 15

Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women’s Care

GlobeNewswire
·
Sep 15

Safe Harbor to Address Banking and Capital Access for Colorado Cannabis Operators at IgniteIt Market Spotlight 2026

GlobeNewswire
·
Sep 15

U.S. Stocks on the MOVE-Eli Lilly, Waystar, Sysco

Reuters
·
Sep 15

FTC Solar - Tracker Production for Sybella Creek Project Underway with Deliveries End 2026-Early 2027

THOMSON REUTERS
·
Sep 15

FTC Solar - Receives Notice to Begin Production for Sybella Creek Solar Farm in Australia

THOMSON REUTERS
·
Sep 15

Gartner® Names Kaltura the Company to Beat in the AI Race for Video Platform Services AI report, Published in August, 2026

GlobeNewswire
·
Sep 15

Allarity Therapeutics Granted Japanese Patent for Stenoparib DRP® Companion Diagnostic, Further Strengthening Stenoparib Development

GlobeNewswire
·
Sep 15

Upexi to Host Fiscal Year 2026 Earnings Call on Thursday, September 17th at 5:30 P.M. ET

GlobeNewswire
·
Sep 15

Intel, Sandisk, Palantir, Coinbase, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 15

Circle, Coinbase Fall Ahead Of Pivotal Procedural Vote On The CLARITY Act

Options & Short Sell
·
Sep 15

Vera Therapeutics Shares Gain on Positive Late-Stage Trial Results

Dow Jones
·
Sep 15

Vera Therapeutics Reports Successful TRUTAKNA Phase 3 Results

TIPRANKS
·
Sep 15

Top Premarket Gainers

MT Newswires Live
·
Sep 15

Crypto Equities Slide Ahead of Pivotal Senate Vote on Market Structure Bill

Stock News
·
Sep 15

Vera Therapeutics up 13% in pre-market at $38.63 after trutakna ORIGIN 3 data

TIPRANKS
·
Sep 15

Vera Therapeutics Gains After Kidney Disease Drug Meets Goals in Confirmatory Trial

Reuters
·
Sep 15

Vera Therapeutics’ trutakna meets all efficacy endpoints in IgAN trial

TIPRANKS
·
Sep 15

Vera Therapeutics, - Trutakna Demonstrates Favorable Safety Profile Generally Comparable to Placebo

THOMSON REUTERS
·
Sep 15

Vera Therapeutics, - Plans to Submit Supplemental Bla to FDA for Full Approval in Q4 2026

THOMSON REUTERS
·
Sep 15